Xiaoyu Li

Title: Xiaoyu Li: Innovator in Cell Culture Technology

Introduction

Xiaoyu Li is a prominent inventor based in Anhui, China. She has made significant contributions to the field of biotechnology, particularly in the development of cell culture technologies. Her innovative work has the potential to advance research in cancer treatment and cellular biology.

Latest Patents

Xiaoyu Li holds a patent for a "Primary gastrointestinal stromal tumor cell culture medium, culture method and application thereof." This invention provides a specialized cell culture medium designed for culturing primary gastrointestinal stromal tumor cells. The medium comprises gastrin, N2, insulin, a receptor tyrosine kinase ligand, and a Rock kinase inhibitor. Additionally, the patent outlines a method for culturing these tumor cells and describes applications for an expanded cell population obtained through this method, which can be utilized in efficacy evaluation or screening.

Career Highlights

Xiaoyu Li is currently employed at Precedo Pharmaceuticals Co., Ltd. Her role at the company allows her to apply her expertise in cell culture and contribute to the development of innovative solutions in the pharmaceutical industry.

Collaborations

Xiaoyu Li collaborates with notable colleagues, including Qingsong Liu and Feiyang Liu. These partnerships enhance her research efforts and foster a collaborative environment for innovation.

Conclusion

Xiaoyu Li's contributions to cell culture technology exemplify her dedication to advancing scientific research. Her patent and work at Precedo Pharmaceuticals Co., Ltd. highlight her role as a key innovator in the field.